OpenVSafe by OpenVAERS
Search V-safe

79Y-30691-51164

2 vaccinations 6 coded responses 8 check-ins 6 free-text entries 4 call cases
Sex
Female
Age at first dose
51-55
ZIP prefix
982 / WA
Registered
2021-05-14
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-09
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-29
    Dose 2 — Pfizer-BioNTech
  3. 2021-05-14
    Registered in v-safe
  4. 2021-05-14
    Survey response — day 14, dose 2
    MedDRA: Decreased appetite, Flushing, Hot flush, Pre-existing disease — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities
    Free text: Repeated arrythmias (PVCs/PACs), hot and cold flashes without fever. Lack of appetite.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-05-20
    Survey response — day 21, dose 2
    MedDRA: Arrhythmia, Condition aggravated, Fatigue, Feeling cold, Hot flush, Pre-existing disease — Feeling: Poor · Be unable to work
    Free text: Severe fatigue, flare of autoimmune disease, ESR of 55, CRP 0.09, rise in auto-antibodies, arrythmia, hot/cold flashes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-27
    Health check-in — day 28, dose 2
    Feeling: Poor
    Adult check-in
  7. 2021-06-03
    Survey response — day 35, dose 2
    MedDRA: Arrhythmia — Feeling: Poor · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Nighttime cardiac arrhythmias. I am now on a 2 week holter monitor.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-06-03
    Report sent to call center — day 35, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  9. 2021-06-10
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  10. 2021-07-29
    Survey response — 3 months, dose 2
    MedDRA: Fatigue, Injection site pain, Neuralgia — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Worsening of injection site pain; now with nerve involvement. Still extremely fatigued post second injection.
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  11. 2021-07-29
    Report sent to call center — 3 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  12. 2021-08-09
  13. 2021-08-09
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  14. 2021-10-28
    Survey response — 6 months, dose 2
    MedDRA: Herpes zoster — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: I have developed a 3-1/2 month course of disseminated shingles that is still ongoing.
    MedDRA releases: 2024-11 · check-in free text available
  15. 2021-10-28
    Report sent to call center — 6 months, dose 2
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  16. 2021-10-29
  17. 2021-11-03
  18. 2021-11-09
    Call successful
    Reported to VAERS voluntarily prior to GDIT contact
  19. 2022-04-29
    Survey response — 12 months, dose 2
    MedDRA: Blood immunoglobulin G increased, Condition aggravated, Herpes zoster, Pre-existing disease — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: exacerbation of MCAS to cutaneous mastocytosis temperature dysregulation reactivation of EBV with high viral IgG still with post Pfizer #2 chronic shingles with high viral IgG now unexplained macrocytosis in the context of sufficient B12 and folate
    MedDRA releases: 2024-11 · check-in free text available
  20. 2022-04-29
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  21. 2022-05-02
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12021-04-09Pfizer-BioNTech
22021-04-29Pfizer-BioNTech

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 4

See the call center timeline

Free text

Release 8 — day 14, dose 2

2021-05-14

Symptoms: Repeated arrythmias (PVCs/PACs), hot and cold flashes without fever. Lack of appetite.

Release 8 — day 21, dose 2

2021-05-20

Symptoms: Severe fatigue, flare of autoimmune disease, ESR of 55, CRP 0.09, rise in auto-antibodies, arrythmia, hot/cold flashes.

Release 8 — day 35, dose 2

2021-06-03

Symptoms: Nighttime cardiac arrhythmias. I am now on a 2 week holter monitor.

Release 9 — 3 months, dose 2

2021-07-29

Symptoms: Worsening of injection site pain; now with nerve involvement. Still extremely fatigued post second injection.

Release 10 — 6 months, dose 2

2021-10-28

Symptoms: I have developed a 3-1/2 month course of disseminated shingles that is still ongoing.

Release 11 — 12 months, dose 2

2022-04-29

Symptoms: exacerbation of MCAS to cutaneous mastocytosis temperature dysregulation reactivation of EBV with high viral IgG still with post Pfizer #2 chronic shingles with high viral IgG now unexplained macrocytosis in the context of sufficient B12 and folate cut off by CDC

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDArrhythmia ✓ ✓ ✓
SDBlood immunoglobulin G increased · · ✓
SDCondition aggravated ✓ ✓ ✓
SDDecreased appetite ✓ ✓ ✓
SDFatigue ✓ ✓ ✓
SDFeeling cold ✓ ✓ ✓
SDFlushing ✓ ✓ ✓
SDHerpes zoster · · ✓
SDHot flush ✓ ✓ ✓
SDInjection site pain ✓ · ✓
SDNeuralgia ✓ · ✓
SDPre-existing disease ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release